Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 294 participants.
Also called NCT04624295
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 294 participants
- Sponsor
- Affiliated Hospital of Jiaxing University
- Huzhou Central Hospital
- Jinhua Central Hospital
- Lishui Country People's Hospital
- Ningbo Medical Center Lihuili Hospital
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Shaoxing People's Hospital
- Shenzhen Second People's Hospital
- Taizhou Hospital
- The Affiliated Hospital of Xuzhou Medical University
- The Second Affiliated Hospital of Jiaxing University
- Registry
-
NCT04624295
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04624295. Randomized; double masking; primary purpose treatment. Start 2021-01-01 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
- Condition
- Antiplatelet Therapy
- Condition
- Hemorrhagic Infarction
- Intervention (Drug)
- Early aspirin Therapy
- Intervention (Drug)
- Non-Early aspirin Therapy
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- Shaoxing People's Hospital
- Collaborator
- Affiliated Hospital of Jiaxing University
- Collaborator
- Huzhou Central Hospital
- Collaborator
- The Second Affiliated Hospital of Jiaxing University
- Collaborator
- Jinhua Central Hospital
- Collaborator
- Taizhou Hospital
- Collaborator
- Ningbo Medical Center Lihuili Hospital
- Collaborator
- Ningbo No.2 Hospital
- Collaborator
- Lishui Country People's Hospital
- Collaborator
- Wenzhou Central Hospital
- Collaborator
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Collaborator
- Shenzhen Second People's Hospital
- Collaborator
- The Affiliated Hospital of Xuzhou Medical University
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 11
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 49 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
Record details
- Record id
cardio:ct-nct04624295- Content hash
53fabe63b419bbc02e99bc1b46a9de18c732f741c4db4117e665678575369227